Manufacture

Cures for all presents a real focus for the next decade – but companies must be rewarded for their work.

How will the adoption of novel approaches to the development of excipients help overcome the challenges of poorly soluble APIs?

"Moving beyond Cas9 may be the secret to reducing CRISPR’s off-target effects," says Garrett Rettig.

We must never forget unmet needs when developing new medicines.

Meet two companies that are advancing pharmaceutical development and manufacture.

Can new tools lower the hurdle of high manufacturing costs for cell and gene therapies?

After a vibrant year of advances in pharmaceutical development and manufacturing technologies, we present The Medicine Maker 2019 Innovation Awards.

Now that Gene therapy's promise has been shown, the industry must focus on improving the manufacturing process and bring down costs.

Free “virtual assistant” tools offer a starting point for formulation – and easier access to regulatory documentation and other enabling information.

Glad tidings of progress and confidence this (conference) season! But let’s not dismiss the emerging skills challenge as “humbug.”